Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 51660-077

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 51660-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohm Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaif-pseuso (Guaifenesin Pseudo 01)

Packaging label for Guaifenesin and Pseudoephedrine HCl Extended-Release Tablets by Ohm Laboratories, Inc. Each tablet contains 600 mg of Guaifenesin and 60 mg of Pseudoephedrine HCl. It is an oral extended-release tablet used as an expectorant and nasal decongestant with a 12-hour duration. The package contains 18 tablets.*

FDA Label Image

Guai-pseudo-02 (Guaifenesin Pseudo 02)

Packaging label for Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets by Ohm Laboratories, Inc. The box contains 12 extended-release tablets indicated as expectorant and nasal decongestant with 12-hour duration. The label highlights clearing nasal/sinus congestion and thinning mucus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.